Organ Recovery Systems’ Post

📣 Attention to everyone attending the 22nd International Congress of ESTIV 2024. Don't miss our Presentation - A Sensitive and Robust Human Liver Microphysiological System for Assessing Drug-Induced Liver Injury. 📅 Date: 4 June 2024, Tuesday 🕣Time: 12:20 pm 📍Track: 3B - Organ-on-a-Chip and Microphysiological Systems Dr. Ovidiu Novac will discuss how our PhysioMimix® OOC liver-on-a-chip demonstrates better sensitivity and specificity over 2D primary hepatocyte culture and even some non-MPS 3D models, when predicting human-specific DILI, matching clinical data to highlight its clinical translatability. 👉 More information: https://bit.ly/3R0gSqz #CNBioAt #ESTIV2024 #OrganOnChip

🎓 Are you a year or so into your career in transplantation & cellular therapies? The Clinical Education Conference has a special beginners' track designed just for you! Learn from case studies & grow your expertise. View the full agenda: https://ow.ly/7tHM50SkS57 #CEC24

Here is a brief description of our recent work on lung regeneration https://lnkd.in/g2Dj3pRB and publication: https://lnkd.in/gxG4r73c

Learn about CMS' Increasing Organ Transplant Access (IOTA) Model, a proposed mandatory initiative with new requirements for transplant hospitals in this article by Georgia Green, MS, CHFP and Steven Hartley with Moss Adams. Set to begin January 1, 2025, this six-year mandatory program focuses on increasing the availability and efficiency of kidney transplants through performance-based payment incentives. 

🌟🔬 We are thrilled to announce that one of our researchers, Prof. Lucio Barile, has contributed as a co-author to a State of The Art Review published in the European Heart Journal (EHJ)! This article outlines the crucial role of extracellular vesicles in therapeutic applications for treating cardiac infarction.   👨🔬 Prof. Lucio Barile collaborated with one of the world's leading experts in the field, Prof. Eduardo Marbán, to provide a comprehensive analysis of the potential of these vesicles in improving clinical outcomes and promoting cardioprotection. #EOC #LRT #cardiocentro

Dear Colleagues, A recent study published in Medical Science Monitor presents a cost-effectiveness comparison between hepatic arterial infusion chemotherapy (HAIC-FO) and sorafenib for advanced hepatocellular carcinoma (HCC) patients in China. Utilizing a Markov model, the study found that HAIC-FO improves survival and is a cost-effective first-line treatment, achieving an additional 0.41 quality-adjusted life years (QALYs) at an incremental cost of $9,720 per QALY gained. This analysis underscores the potential of HAIC-FO to optimize patient outcomes within the Chinese healthcare system. The complete report is now available on the Medical Science Monitor webpage. | https://lnkd.in/dbBUtZz7

No injection time limits is a key reason why Dr. Zachary Klaassen uses Barrigel. Hear from other physicians on why they choose Barrigel for their #prostatecancer patients undergoing radiation therapy: https://lnkd.in/gNzJfFTV The testimonial is based on the personal experience and learnings of the featured healthcare professional. Reference: Mariados NF, Orio PF III, Schiffman Z et al. Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial. JAMA Oncol. 2023: e1-e8. #controlmatters #Barrigel #prostatecancer

Higher polygenic risk score (PRS) was associated with an increased risk for primary open-angle #glaucoma (#POAG) in patients with ocular #hypertension, according to a post-hoc analysis of the Ocular Hypertension Treatment Study. Among over 1,000 patients, risk of POAG increased 1.36% with each higher PRS decile, with conversion ranging from 9.52% in the lowest decile to 21.81% in the highest decile, as per a study from researchers at Washington University School of Medicine in St. Louis; Medical College of Wisconsin; University of Maryland; Devers Memorial Eye Clinic; Bascom Palmer Eye Institute and Creighton University School of Medicine; as well as participating clinics. Comparing the low-risk and high-risk PRS tertiles showed a twofold increase in 20-year POAG risk for patients of European and African ancestries. Primary findings from the Ocular Hypertension Treatment Study showed that topical ocular hypotensive medication was effective in delaying or preventing the onset of POAG in patients with elevated intraocular pressure. Academic article -> https://bit.ly/3VnCzE4

Learn about CMS' Increasing Organ Transplant Access (IOTA) Model, a proposed mandatory initiative with new requirements for transplant hospitals in this article by Georgia Green, MS, CHFP and Steven Hartley with Moss Adams. Set to begin January 1, 2025, this six-year mandatory program focuses on increasing the availability and efficiency of kidney transplants through performance-based payment incentives.